MMP27 is a matrix metalloproteinase that degrades extracellular matrix components including collagens, fibronectin, and laminin through metalloendopeptidase activity 1. The protein is regulated during endometrial decidualization, where it is significantly downregulated in decidualized endometrial stromal cells treated with progesterone receptor agonists, suggesting a role in reproductive tissue remodeling 2. In cancer contexts, MMP27 has been identified as a genetic marker associated with osteosarcoma prognosis, with altered expression patterns correlating with patient survival outcomes 3. A genetic polymorphism near MMP27 (rs7129790) is associated with increased abundance of proinflammatory Proteobacteria in the gut microbiome and is more prevalent in Mexican Americans with type 2 diabetes, suggesting a potential link between MMP27 genetic variation and metabolic disease susceptibility 4. Additionally, MMP27 expression is altered in male breast cancer sera 5, and placental MMP27 methylation changes are associated with maternal anxiety-induced atopic dermatitis risk in offspring 1. Unlike some cancers, MMP27 mutations are rare or absent in thyroid cancer 6. Overall, MMP27 functions in extracellular matrix remodeling and may serve as a biomarker in disease pathogenesis across reproductive, metabolic, and malignant conditions.